文献速递骨质疏松与代谢性骨病

太极拳运动对骨骼健康有效性与安全性的伞状综述

Efficacy and safety of tai chi exercise on bone health: An umbrella review.
PubMed 文献 · Osteoporos Int · 2023-07-10

该伞状综述系统检索了截至2023年3月的18篇系统综述(15篇含Meta分析),采用PRISMA、AMSTAR-2和GRADE工具评价。结果显示,围绝经期和绝经后女性练习太极拳可能改善腰椎和股骨颈骨密度,老年人可能在股骨颈、股骨近端转子及Ward三角骨密度获益,但证据确定性低。

要点

  • 围绝经期和绝经后女性练习太极拳可能改善腰椎和股骨颈骨密度(证据确定性低)。
  • 老年人练习太极拳可能在股骨颈、股骨近端转子及Ward三角骨密度获益(证据确定性低)。
  • 多数纳入系统综述的AMSTAR-2评分为极低,报告质量高低不一。

核心结论

  • 证据确定性低:与不运动相比,太极拳可能改善围绝经期和绝经后女性的腰椎和股骨颈骨密度。
  • 证据确定性低:老年人练习太极拳可能在股骨颈和Ward三角骨密度获益。

研究设计与样本

  • 伞状综述,纳入18篇系统综述(其中15篇含Meta分析),共纳入49项随机对照试验(3956例参与者)和16项非随机干预研究(1157例参与者)。
  • 检索8个电子数据库及PROSPERO注册库,检索时间从建库至2023年3月。
  • 采用更新版PRISMA清单、AMSTAR-2和GRADE方法评价纳入系统综述的报告质量、方法学质量和证据确定性。

主要发现

  • 围绝经期和绝经后参与者练习太极拳与非干预相比,腰椎骨密度MD=0.04(95%CI 0.02, 0.07),股骨颈骨密度MD=0.04(95%CI 0.02, 0.06),股骨近端转子骨密度MD=0.02(95%CI 0.00, 0.03),Ward三角骨密度MD=0.02(95%CI -0.01, 0.04),股骨干骨密度SMD=0.16(95%CI -0.11, 0.44)。
  • 老年人练习太极拳与非干预相比,股骨颈骨密度SMD=0.28(95%CI 0.10, 0.45),股骨近端转子骨密度SMD=0.39(95%CI 0.05, 0.73),Ward三角骨密度SMD=0.21(95%CI 0.05, 0.37),腰椎骨密度SMD=0.03(95%CI -0.22, 0.27)。
  • 纳入系统综述的报告质量范围为高至低,但大多数AMSTAR-2评分为极低。
  • 探索了太极拳对9种骨骼健康生物标志物的有效性,涵盖骨密度和血清生物标志物。

关键数值与推荐

  • 围绝经期和绝经后女性腰椎骨密度MD=0.04(95%CI 0.02, 0.07),股骨颈骨密度MD=0.04(95%CI 0.02, 0.06)。
  • 老年人股骨颈骨密度SMD=0.28(95%CI 0.10, 0.45),股骨近端转子骨密度SMD=0.39(95%CI 0.05, 0.73),Ward三角骨密度SMD=0.21(95%CI 0.05, 0.37)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 大多数纳入系统综述的AMSTAR-2评分为极低。
  • 证据确定性低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To critically evaluate systematic reviews (SRs) of the Tai Chi (TC) exercise on bone health and provide more recently available evidence. METHODS: SRs with or without meta-analysis (MA) of TC on bone health were comprehensively searched in eight electronic databases (PubMed, EMBASE, Cochrane Library, Web of Science, China National Knowledge Infrastructure, Wanfang Database, Chinese Biomedical Literature Database, and Chinese Scientific Journals Database) and in the international prospective register of systematic reviews of (PROSPERO) from initiation to March 2023. Descriptive analyses of SRs were performed, and reporting and methodological quality of the included SRs were evaluated using the updated version of Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist and A Measurement Tool to Assess Systematic Reviews 2 (AMSTAR-2). The certainty of the synthesized evidence was assessed with the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach. RESULTS: Eighteen SRs, 15 with MAs, were included. Forty-nine RCTs and 16 NRSIs with 3956 and 1157 participants, respectively, were included in these SRs. The reporting quality of the included SRs ranged from high to low, but most received critically low AMSTAR-2 scores. Efficacy of TC on nine bone health biomarkers has been explored, covering bone mineral density (BMD) and serum biomarkers. The results showed that compare to non-intervention, perimenopausal and postmenopausal participants who practiced TC may benefit in BMD of the lumbar spine [MD = 0.04, 95% CI (0.02, 0.07)], and femoral neck [MD = 0.04, 95% CI (0.02, 0.06)], but not BMD of the femoral proximal trochanter [MD = 0.02, 95% CI (0.00, 0.03)], ward's triangle [MD = 0.02, 95% CI (-0.01, 0.04)], and femoral shaft [SMD = 0.16, 95% CI (-0.11, 0.44)]. Elders practicing TC may benefit in BMD of the femoral neck [SMD = 0.28, 95% CI (0.10, 0.45)], femoral proximal trochanter [SMD = 0.39, 95% CI (0.05, 0.73)], and ward's triangle [SMD = 0.21, 95% CI (0.05,0.37)], but may not in BMD of lumbar spine [SMD = 0.03, 95% CI (-0.22, 0.27)]. CONCLUSION: We have low certainty that for perimenopausal and postmenopausal women, compare to those with no exercise, TC could improve BMD of the lumbar spine, femoral neck. We also have low certainty that in elder population, TC practitioners may benefit in BMD of femoral neck, and Ward's triangle. REGISTRATION: PROSPERO (CRD42020173543).

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Li J, Guo J, Wang X, et al. Efficacy and safety of tai chi exercise on bone health: An umbrella review. Osteoporos Int. 2023. PMID: 37430003. doi:10.1007/s00198-023-06830-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。